Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3463)
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
206,005
Price
$15.28
Total Value
$3.15M
Shares Held After
13,044,106
% of Holdings
1.6%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
349
Price
$4.46
Total Value
$1.56K
Shares Held After
181,509
% of Holdings
0.2%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$16.60
Total Value
$135.25K
Shares Held After
13,579
% of Holdings
37.5%
Axsome Therapeutics, Inc. (AXSM)
Coleman Mark — Director
Shares
5,537
Price
$223.39
Total Value
$1.24M
Shares Held After
29,603
% of Holdings
15.8%
HYPERION DEFI, INC. (HYPD)
Jung Hyunsu — Director
Shares
500
Price
$3.68
Total Value
$1.84K
Shares Held After
1,385,676
% of Holdings
0.0%
HYPERION DEFI, INC. (HYPD)
Jung Hyunsu — Director
Shares
500
Price
$3.64
Total Value
$1.82K
Shares Held After
1,385,176
% of Holdings
0.0%
Ascendis Pharma A/S (ASND)
SMITH SCOTT THOMAS — EVP & Chief Financial Officer
Shares
100
Price
$219.00
Total Value
$21.90K
Shares Held After
4,367
% of Holdings
2.3%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
99
Price
$15.34
Total Value
$1.52K
Shares Held After
12,838,101
% of Holdings
0.0%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
343,521
Price
$15.28
Total Value
$5.25M
Shares Held After
12,838,002
% of Holdings
2.7%
GENELUX Corp (GNLX)
Thomas John — Director
Shares
10,000
Price
$2.98
Total Value
$29.80K
Shares Held After
472,784
% of Holdings
2.1%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
3,977
Price
$100.00
Total Value
$397.70K
Shares Held After
0
% of Holdings
100.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
883
Price
$99.66
Total Value
$88.00K
Shares Held After
194,309
% of Holdings
0.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
1,021
Price
$98.20
Total Value
$100.26K
Shares Held After
195,192
% of Holdings
0.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
1,973
Price
$97.56
Total Value
$192.49K
Shares Held After
196,213
% of Holdings
1.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
6,926
Price
$96.15
Total Value
$665.93K
Shares Held After
198,186
% of Holdings
3.4%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
16,595
Price
$95.34
Total Value
$1.58M
Shares Held After
205,112
% of Holdings
7.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
2,602
Price
$94.64
Total Value
$246.25K
Shares Held After
221,707
% of Holdings
1.2%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Director
Shares
9,747
Price
$9.62
Total Value
$93.77K
Shares Held After
130,079
% of Holdings
7.0%
CORCEPT THERAPEUTICS INC (CORT)
BELANOFF JOSEPH K — Director
Shares
12,837
Price
$69.74
Total Value
$895.25K
Shares Held After
2,565,489
% of Holdings
0.5%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
468
Price
$19.73
Total Value
$9.23K
Shares Held After
594,538
% of Holdings
0.1%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
4,998
Price
$19.41
Total Value
$97.02K
Shares Held After
595,006
% of Holdings
0.8%
NovaBridge Biosciences (NBP)
Xu Cong Claire — SVP, Clinical Development
Shares
3,494
Price
$3.94
Total Value
$13.77K
Shares Held After
290,154
% of Holdings
1.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
4,159
Price
$91.37
Total Value
$380.01K
Shares Held After
4,000
% of Holdings
51.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
16,943
Price
$90.72
Total Value
$1.54M
Shares Held After
8,159
% of Holdings
67.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
5,428
Price
$89.72
Total Value
$487.00K
Shares Held After
25,102
% of Holdings
17.8%
Axsome Therapeutics, Inc. (AXSM)
Coleman Mark — Director
Shares
6,000
Price
$230.30
Total Value
$1.38M
Shares Held After
35,140
% of Holdings
14.6%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,667
Price
$6.06
Total Value
$100.98K
Shares Held After
1,176,506
% of Holdings
1.4%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
200
Price
$230.41
Total Value
$46.08K
Shares Held After
41,382
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,216
Price
$229.47
Total Value
$279.03K
Shares Held After
41,582
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
584
Price
$228.57
Total Value
$133.49K
Shares Held After
42,798
% of Holdings
1.3%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
400
Price
$226.78
Total Value
$90.71K
Shares Held After
43,382
% of Holdings
0.9%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,432
Price
$225.97
Total Value
$323.59K
Shares Held After
43,782
% of Holdings
3.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
677
Price
$225.20
Total Value
$152.46K
Shares Held After
45,214
% of Holdings
1.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
491
Price
$223.95
Total Value
$109.96K
Shares Held After
45,891
% of Holdings
1.1%
HYPERION DEFI, INC. (HYPD)
Jung Hyunsu — Director
Shares
2,000
Price
$3.81
Total Value
$7.62K
Shares Held After
1,384,676
% of Holdings
0.1%
HYPERION DEFI, INC. (HYPD)
Jung Hyunsu — Director
Shares
5,000
Price
$3.66
Total Value
$18.30K
Shares Held After
1,382,676
% of Holdings
0.4%
4D Molecular Therapeutics, Inc. (FDMT)
Kirn David — Director
Shares
1,922
Price
$10.02
Total Value
$19.26K
Shares Held After
1,057,231
% of Holdings
0.2%
Vir Biotechnology, Inc. (VIR)
Sabatini Brent — SVP, Chief Accounting Officer
Shares
379
Price
$9.45
Total Value
$3.58K
Shares Held After
61,902
% of Holdings
0.6%
Vir Biotechnology, Inc. (VIR)
Napolitano Janet — Director
Shares
3,200
Price
$9.45
Total Value
$30.24K
Shares Held After
21,216
% of Holdings
13.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,625
Price
$66.21
Total Value
$107.59K
Shares Held After
43,669
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$554.43
Total Value
$221.77K
Shares Held After
40,513
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$552.82
Total Value
$132.68K
Shares Held After
40,913
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
124
Price
$550.82
Total Value
$68.30K
Shares Held After
41,153
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,070
Price
$550.26
Total Value
$588.77K
Shares Held After
41,277
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,166
Price
$549.31
Total Value
$640.50K
Shares Held After
42,347
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,546
Price
$548.21
Total Value
$847.53K
Shares Held After
43,513
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,376
Price
$547.11
Total Value
$752.82K
Shares Held After
45,059
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,213
Price
$546.21
Total Value
$1.21M
Shares Held After
46,435
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,365
Price
$545.04
Total Value
$743.98K
Shares Held After
48,648
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$554.47
Total Value
$221.79K
Shares Held After
18,876
% of Holdings
2.1%
Showing 1–50 of 3463 transactions (page 1 of 70)